Skip to content

A Clinical Trial of the Transcendental Meditation (TM) Program on Blood Pressure, Psychological Distress, and Coping

A Randomized Controlled Trial of the Transcendental Meditation Program on Blood Pressure, Psychological Distress, and Coping in Young Adults

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00924456
Acronym
AU
Enrollment
296
Registered
2009-06-19
Start date
2006-01-31
Completion date
2007-05-31
Last updated
2022-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High-normal Blood Pressure, Psychological Stress

Keywords

Transcendental Meditation, blood pressure, psychological distress, high psychological distress

Brief summary

The purpose of this trial is to show that the Transcendental Meditation program can decrease blood pressure in young adults (college students) and is associated with decreased psychological distress and coping ability.

Detailed description

Psychological distress contributes to the development of hypertension in young adults. This was a randomized controlled trial of 296 university students randomly allocated to either the Transcendental Meditation® program or wait-list control. At baseline and after three months posttest, systolic and diastolic blood pressure, psychological distress (total mood disturbance, anxiety, depression, anger/hostility) and coping ability (global constructive thinking) were measured.

Interventions

a natural effortless mental technique

Sponsors

American University
CollaboratorOTHER
Abramson Family Foundation
CollaboratorOTHER
Maharishi International University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
16 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* male or female * currently enrolled in an undergraduate or graduate program through August 2006

Exclusion criteria

* history of: * hypertension * hypoglycemia * chronic fainting * coronary heart disease * current systolic/diastolic blood pressure above 140/90 mm Hg or below 90/60 mm Hg

Design outcomes

Primary

MeasureTime frame
clinic systolic and diastolic blood pressure3 months

Secondary

MeasureTime frame
psychological distress (anxiety, depression, anger/hostility) and coping (constructive thinking)3 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026